ACT-1004-1239 matching placebo
ID-086B201
Phase 2 small_molecule active
Quick answer
ACT-1004-1239 matching placebo for Progressive multiple sclerosis (MS) is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- Progressive multiple sclerosis (MS)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active